May 15
|
Moffitt and Fulgent Pharma partner on personalised cancer therapies
|
May 14
|
Moffitt Cancer Center and Fulgent Pharma Join Forces to Revolutionize Cancer Therapeutics
|
May 6
|
Fulgent Genetics First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
|
May 4
|
Fulgent Genetics, Inc. (NASDAQ:FLGT) Q1 2024 Earnings Call Transcript
|
May 4
|
Fulgent Genetics Inc (FLGT) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges ...
|
May 4
|
Q1 2024 Fulgent Genetics Inc Earnings Call
|
May 3
|
Fulgent Genetics Inc (FLGT) Q1 2024 Earnings: Misses Analyst Forecasts with Wider Losses
|
May 3
|
Fulgent Genetics, Inc. (FLGT) Reports Q1 Loss, Misses Revenue Estimates
|
May 3
|
Fulgent Reports First Quarter 2024 Financial Results
|
Apr 11
|
Fulgent Genetics to Announce First Quarter 2024 Financial Results on Friday, May 3, 2024
|
Apr 11
|
Fulgent Genetics (NASDAQ:FLGT) shareholders have earned a 26% CAGR over the last five years
|
Aug 5
|
Fulgent Genetics, Inc. (NASDAQ:FLGT) Q2 2023 Earnings Call Transcript
|
Aug 5
|
Q2 2023 Fulgent Genetics Inc Earnings Call
|
Aug 4
|
Fulgent Genetics, Inc. (FLGT) Reports Q2 Loss, Tops Revenue Estimates
|
Aug 4
|
Fulgent Reports Second Quarter 2023 Financial Results
|